 | | Vol. 12.05 – 8 February, 2023 |
| |
|
|
| Researchers reported a new proton (H+) modulation approach to selectively eradicate CSCs via cutting off the H+ leaks on the inner mitochondrial membrane.
[Journal of the American Chemical Society] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| In glioblastoma CSCs, WDR5 inhibitors blocked WRAD complex assembly and reduced H3K4 trimethylation and expression of genes involved in CSC-relevant oncogenic pathways.
[Genes & Development] |
|
|
|
| Investigators described a concise three-gene expression signature, leukemic stem cell-3, as an independent and robust prognostic factor for leukemia-free and overall survival in chronic myelomonocytic leukemia.
[British Journal Of Haematology] |
|
|
|
| Scientists showed that the acute myeloid leukemia-specific autocrine loop constituted of T cell immunoglobulin mucin-3 (TIM-3) and its ligand, galectin-9, drove the canonical Wnt pathway to stimulate self-renewal and propagation of leukemic stem cells.
[Blood Advances] |
|
|
|
| Circulating tumor cells were analyzed in patients with metastatic prostate cancer during radiotherapy with CellSearch, multi-color flow cytometry, and imaging cytometry.
[International Journal of Cancer] |
|
|
|
| The authors studied the effects of low-dose human phthalate exposure on breast CSCs to explore its underlying mechanism as they remain largely unexplored.
[Ecotoxicology and Environmental Safety] |
|
|
|
| Scientists established two radioresistant colorectal cancer (CRC) cell lines, HCT116-R and RKO-R, using fractionated irradiation to explore the role of CSCs in regulating resistance to radiotherapy in CRC.
[Cell Death Discovery] |
|
|
|
| Researchers investigated the potential mechanism for transient EBV/LMP1 exposure‑mediated persistent peroxisome proliferator‑activated receptor‑γ coactivator‑1β (PGC1β) expression and subsequent tumorigenesis through modification of mitochondrial function.
[Oncology Reports] |
|
|
|
| Investigators used genetic approaches to specifically label CSC-derived extracellular vesicles and to perform Sortase-mediated in vivo proximity labeling of CSC niche cells.
[PLOS One] |
|
|
|
| Scientists revealed the contribution of SEC61 translocon subunit gamma (SEC61G) in promoting cisplatin-induced CSC properties of head and neck squamous cell carcinoma cells via promoting Ca2+-mediated autophagy.
[Journal of Dental Sciences] |
|
|
|
|
| The authors focus on E3 ubiquitin ligases and their roles and mechanisms in regulating essential hallmarks of CSCs, such as self-renewal, invasion and metastasis, immune evasion, and more.
[Cellular Oncology] |
|
|
|
|
| Former universities minister Michelle Donelan has been appointed head of the newly-created Department for Science, Innovation, and Technology in a mini-reshuffle.
[Nature] |
|
|
|
|
| February 22 – 23, 2023
Boston, Massachusetts, United States |
|
|
|
|
|
| | Howard Hughes Medical Institute – Dallas, Texas, United States |
|
|
|
| | Virginia Commonwealth University – Richmond, Virginia, United States |
|
|
|
| | The International Institute of Molecular and Cell Biology – Warsaw, Poland |
|
|
|
| | Beckman Research Institute – Monrovia, California, United States |
|
|
|
| | Essen University Hospital – Essen, Germany |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
